"Lung cancer is the most lethal cancer in the world today. There are limited options for clinicians when treating patients, with only 10-15% of lung cancer patients surviving their malignancy. Despite the introduction of new chemotherapies, lung cancer survival is unchanged from thirty years ago. New ways of treating this disease are needed. We hypothesise that modified mesenchymal stem cells (MSC ...